These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 17881329
1. Efficacy and safety of insulin detemir. Raskin P. Endocrinol Metab Clin North Am; 2007 Aug; 36 Suppl 1():21-32. PubMed ID: 17881329 [Abstract] [Full Text] [Related]
4. Spotlight on insulin detemir in type 1 and 2 diabetes mellitus. Chapman TM, Perry CM. BioDrugs; 2005 Aug; 19(1):67-9. PubMed ID: 15691219 [Abstract] [Full Text] [Related]
8. Insulin detemir: a long-acting insulin product. Jones MC, Patel M. Am J Health Syst Pharm; 2006 Dec 15; 63(24):2466-72. PubMed ID: 17158694 [Abstract] [Full Text] [Related]
10. Insulin detemir in the treatment of type 1 and type 2 diabetes. Philips JC, Scheen A. Vasc Health Risk Manag; 2006 Dec 15; 2(3):277-83. PubMed ID: 17326333 [Abstract] [Full Text] [Related]
11. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort. Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L. Int J Clin Pract; 2007 Mar 15; 61(3):523-8. PubMed ID: 17313628 [Abstract] [Full Text] [Related]
13. PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Lüddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P, Gydesen H, Dornhorst A, PREDICTIVE Study Group. Diabetes Obes Metab; 2007 May 15; 9(3):428-34. PubMed ID: 17391171 [Abstract] [Full Text] [Related]